Delta opioid binding selectivity of 3-ether analogs of naltrindole

Bioorganic and Medicinal Chemistry Letters

Volumn 9, Issue 24, 1999, Pages 3435-3438

  Coop, Andrew ^a,c   Pinto, Julia ^a,d   Wang, Lijuan ^a,e   McCullough, Karen ^a,b   Rothman, Richard B ^a,b   Dersch, Christine ^a,b   Jacobson, Arthur E ^a   Rice, Kenner C ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NIDA Addiction Research Center   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^d Ares Advanced Technology   (United States)

^e MONSANTO COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DELTA OPIATE RECEPTOR; DRUG ANALOG; ETHER DERIVATIVE; KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR; NALTRINDOLE; PHENOL;

ARTICLE; BINDING AFFINITY; CHEMICAL MODIFICATION; DRUG RECEPTOR BINDING; DRUG STRUCTURE; PARTIAL DRUG SYNTHESIS; REDUCTION;

EID: 0033590271     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(99)00622-8     Document Type: Article

References (15)

1. Dondio, G.; Ronzoni, S.; Petrillo, P. Exp. Opin. Ther. Patents. 1997, 7, 1075.
2. Millan, M. J. Trends Pharmacol. Sci. 1990, 11, 70.
3. Rapaka, R. S., Porreca, F. Pharm. Res. 1991, 8, 1.
4. Suzuki, T.; Tsuji, M.; Ikeda, H.; Narita, M.; Tseng, L. F. Life Sci. 1997, 60, 283.
5. Calcagnetti, D. J.; Keck, B. J.; Quatrella, L. A.; Schechter, M. D. Life Sci. 1995, 56, 475.
6. Portoghese, P. S.; Sultana, M.; Takemori, A. E. J. Med. Chem. 1990, 33, 1714.
7. Takemori, A. E.; Portoghese, P. S. Annu. Rev. Pharmacol. Toxicol. 1992, 32, 239.
8. Takemori, A. E.; Sultana, M.; Nagase, H.; Portoghese, P. S. Life Sci. 1992, 50, 1491.
9. Kubota, K; Rothman, R. B.; Dersch, C.; McCullough, K.; Pinto, J.; Rice, K. C. Bioorġ. Med. Chem. Lett. 1998, 8, 799.
10. MVD = Mouse vas deferens; functional assay for δ activity. GPI = Guinea pig ileum; functional assay for μ and κ activity.
11. Maguire, P. A.; Perez, J. J.; Tsai, N. F.; Rodriguez, L.; Beatty, M. F.; Villar, H. O.; Kamal, J. J.; Upton, C.; Casy, A. F.; Loew, G. H. Mol. Pharm. 1993, 44, 1246.
12. Calderon, S. N.; Rice, K. C.; Rothman, R. B.; Porreca, F.; Flippen-Anderson, J. L.; Kayakiri, H.; Xu, H.; Becketts, K.; Smith, L. E.; Bilsksy, E. J.; Davis, P.; Horvath, R. J. Med. Chem. 1997, 40, 695.
13. Coop, A.; Rothman, R. B.; Dersch, C.; Partilla, J.; Porreca, F.; Davis, P.; Jacobson, A. E.; Rice, K. C. J. Med. Chem. 1999, 42, 1673.
14. Coop, A; Pinto, J.; Bertha, C. M.; McCullough, K.; Dersch, C.; Xu, H.; Rothman, R. B.; Rice, K. C. National Institute on Drug Abuse Research Monograph Series 1998, 178, 79.
15. Freebase 11 was dissolved under the assay conditions by the addition of 1 equivalent of HCl. All spectra were consistent with the assigned structures and all novel compounds gave satisfactory microanalyses (CHN) within ±0.4%.